SUPPLEMENTARY INFORMATION
FROM:
Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML
J Cammenga
BACK TO ARTICLEDownload pluginsSupplementary Figure 1 (jpeg 232K)
Expression and activity of the promoters used in different mouse models of AML (excluding MLL and HOX).
Supplementary Table 1 (xls 26K)
Mouse models for AML listed by subtype (excluding translocations involving the MLL and HOX genes). Abbreviations: TG, transgenic; BM, bone marrow; RCR, replication competent retrovirus; ND, not determined; ENU, N-ethyl-N-nitrosourea; ATRA, all-trans retinoic acid; ES cells, embryonic stem cells; APL, acute promyelocytic leukemia; CML-L, CML-like; MPD, myeloproliferative diseases; MDS, myelodysplastic syndromes.
